The estimated Net Worth of Robert G Moussa is at least $9.14 ezer dollars as of 31 October 2006. Robert Moussa owns over 500 units of Daxor stock worth over $9,140 and over the last 18 years Robert sold DXR stock worth over $0.
Robert has made over 2 trades of the Daxor stock since 2006, according to the Form 4 filled with the SEC. Most recently Robert bought 500 units of DXR stock worth $7,645 on 31 October 2006.
The largest trade Robert's ever made was buying 500 units of Daxor stock on 31 October 2006 worth over $7,645. On average, Robert trades about 333 units every 46 days since 2006. As of 31 October 2006 Robert still owns at least 1,000 units of Daxor stock.
You can see the complete history of Robert Moussa stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is 1375 Kings Hwy E, Fairfield, CT 06825, USA.
Over the last 21 years, insiders at Daxor have traded over $7,541,627 worth of Daxor stock and bought 473,408 units worth $2,888,339 . The most active insiders traders include Joseph Feldschuh, Bruce Slovin és Robert J Michel. On average, Daxor executives and independent directors trade stock every 39 days with the average trade being worth of $27,740. The most recent stock trade was executed by Robert J Michel on 27 March 2024, trading 750 units of DXR stock currently worth $6,525.
the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.
Daxor executives and other stock owners filed with the SEC include: